Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis
This is a study that will evaluate the utility of a scatter reduction technique in reducing dose and increasing the sensitivity of stationary digital chest tomosynthesis (s-DCT) in the detection of lung lesions.
Checked against the public recordLast updated Aug 8, 2022 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Diagnostic
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Interventions being studied
- Device: Scatter corrected s-DCT
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Patients with known lung lesion(s) * Patients having undergone a chest CT * Patients 18 years of age and older * Patients able to provide informed consent Exclusion Criteria: * Patients who may not fit on a 35 x 35 detector (BMI \> 35) * Planned procedures or therapies during study (in between SOC scans and study scan on s-DCT) (biopsy or removal of lung lesion) * Any woman who is pregnant, has reason to believe she is pregnant, or is lactating
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of North Carolina at Chapel HillChapel Hill, North Carolina
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 8, 2022. Always confirm current availability with the study team.